Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib
Clinical trial NCT03091465 · COMPLETED
Trial details
- NCT number
- NCT03091465
- Sponsor
- Spanish Oncology Genito-Urinary Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-20
- Primary completion
- 2017-04-17
- Enrollment
- 530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.